HiberCell
Latest round
- Series B
Last raised
- May 2021
Total raised
- $110M
Investors
- 11
About HiberCell
HiberCell, Inc.Founded in 2019, HiberCell, Inc. is headquartered in New York, US. The company focuses on developing therapies to combat cancer treatment challenges.HiberCell specializes in innovative cancer therapeutics aimed at treating resistant cancers. Its primary offerings include HC-7366, which activates the GCN2 kinase, and HC-5404, targeting the PERK pathway in cancer cells. Additionally, the company is developing Odetiglucan, which enhances anti-cancer immune responses.HiberCell's revenue is generated through partnerships with pharmaceutical companies and research institutions focused on cancer therapeutics. The company is focused on launching new products designed to address critical oncology challenges, enhancing its market presence and therapeutic offerings as it progresses through clinical trials.
Who invested in HiberCell
11 investors across 2 rounds
See all investors in HiberCell
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about HiberCell
Who invested in HiberCell?
HiberCell has 11 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has HiberCell raised?
HiberCell has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did HiberCell last raise money?
HiberCell's most recent round on record is a Series B, in May 2021.
What does HiberCell do?
HiberCell is a biotechnology company.
Where is HiberCell headquartered?
HiberCell is headquartered in New York, US.
Which VCs invest in companies like HiberCell?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at HiberCell's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like HiberCell? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.